🇺🇸 Randomisation to mepolizumab in United States

Randomisation to mepolizumab (Randomisation to mepolizumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Randomisation to mepolizumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Randomisation to mepolizumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Randomisation to mepolizumab in United States?

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the originator. The local marketing authorisation holder may differ — check the official source linked above.